The decreased SIRT1 expression might be clinically relevant to therapeutic interventions because resveratrol could ameliorate oxidative stress and inflammation via activating SIRT1 in murine COPD models (30). This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.